跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ML-210
首页
药物
ML-210
ML-210
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Application of natural mineral water with special qualities in prophylaxis, hygiene and treatment of teeth and paradontium
申请人: CIESLIK TADEUSZ
优先权: 2008
US
Formula of five-component drug wine with effects of sperm increasing, marrow supplementing, health and health preserving
申请人: ZHENGZHOU WOTIAN FERTILIZER STATION
优先权: 2014
CN
METHOD FOR CONTROLLING IMPURITY OF CYCLOSPORIN A EYE GEL
申请人: ZHAOKE GUANGZHOU OPHTHALMIC DRUG COMPANY LTD
优先权: 2017
CN
EP
US
3 件公开
Six-ingredient spirit-quieting and sleep-promoting health-caring medicinal liquor formula
申请人: ZHENGZHOU WOTIAN FERTILIZER STATION
优先权: 2014
CN
融合蛋白210及其在优化病毒复制中的应用
申请人: 中国农业大学
优先权: 2016
CN
PROCESS FOR PREPARING LIPOSOME-ENCAPSULATED PEPTIDE P33
申请人: ALTAYB HISHAM N
优先权: 2025
US
Method for synthesizing iprindole hydrochloride pharmaceutical intermediate iprindole
申请人: CHENGDU CARDIFF SCIENCE AND TECH CO LTD
优先权: 2015
CN
2 件公开
Synthesis method of miconazole drug intermediate alpha-(2,4-dichlorophenyl)-beta-(1-imidazolyl) ethanol
申请人: XIAMEN ANPTON INFORMATION TECH CO LTD
优先权: 2015
CN
药物
反馈